GoodRx (GDRX) Competitors

$2.49 -0.12 (-4.60%)

Closing price 04:00 PM Eastern

Extended Trading

$2.52 +0.02 (+1.00%)

As of 06:33 PM Eastern

GDRX vs. PAGS, YY, JOYY, SEZL, and XMTR

Should you buy GoodRx stock or one of its competitors? MarketBeat compares GoodRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GoodRx include PagSeguro Digital (PAGS), JOYY (YY), JOYY (JOYY), Sezzle (SEZL), and Xometry (XMTR). These companies are all part of the "business services" industry.

How does GoodRx compare to PagSeguro Digital?

PagSeguro Digital (NYSE:PAGS) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

PagSeguro Digital has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

PagSeguro Digital presently has a consensus price target of $12.00, indicating a potential upside of 33.26%. GoodRx has a consensus price target of $3.81, indicating a potential upside of 53.11%. Given GoodRx's higher probable upside, analysts clearly believe GoodRx is more favorable than PagSeguro Digital.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PagSeguro Digital	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

In the previous week, PagSeguro Digital had 3 more articles in the media than GoodRx. MarketBeat recorded 8 mentions for PagSeguro Digital and 5 mentions for GoodRx. GoodRx's average media sentiment score of 0.59 beat PagSeguro Digital's score of -0.01 indicating that GoodRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PagSeguro Digital	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GoodRx	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PagSeguro Digital has higher revenue and earnings than GoodRx. PagSeguro Digital is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PagSeguro Digital	$20.41B	0.12	$379.40M	$1.28	7.04
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.50

45.9% of PagSeguro Digital shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

PagSeguro Digital has a net margin of 10.37% compared to GoodRx's net margin of 2.61%. PagSeguro Digital's return on equity of 16.20% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PagSeguro Digital	10.37%	16.20%	3.33%
GoodRx	2.61%	7.90%	3.23%

Summary

PagSeguro Digital and GoodRx tied by winning 8 of the 16 factors compared between the two stocks.

How does GoodRx compare to JOYY?

GoodRx (NASDAQ:GDRX) and JOYY (NASDAQ:YY) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

GoodRx has a beta of 1.54, suggesting that its share price is 54% more volatile than the broader market. Comparatively, JOYY has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market.

JOYY has higher revenue and earnings than GoodRx. JOYY is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.50
JOYY	$2.24B	1.43	$301.82M	-$3.10	N/A

In the previous week, GoodRx had 5 more articles in the media than JOYY. MarketBeat recorded 5 mentions for GoodRx and 0 mentions for JOYY. GoodRx's average media sentiment score of 0.59 beat JOYY's score of 0.00 indicating that GoodRx is being referred to more favorably in the media.

Company	Overall Sentiment
GoodRx	Positive
JOYY	Neutral

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 36.8% of JOYY shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 43.0% of JOYY shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

JOYY has a net margin of 9.02% compared to GoodRx's net margin of 2.61%. GoodRx's return on equity of 7.90% beat JOYY's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
JOYY	9.02%	4.64%	2.96%

GoodRx currently has a consensus price target of $3.81, suggesting a potential upside of 53.11%. JOYY has a consensus price target of $66.00, suggesting a potential upside of 10.72%. Given GoodRx's higher possible upside, equities analysts clearly believe GoodRx is more favorable than JOYY.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
JOYY	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

GoodRx beats JOYY on 10 of the 16 factors compared between the two stocks.

How does GoodRx compare to JOYY?

GoodRx (NASDAQ:GDRX) and JOYY (NASDAQ:JOYY) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

JOYY has a net margin of 98.79% compared to GoodRx's net margin of 2.61%. GoodRx's return on equity of 7.90% beat JOYY's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
JOYY	98.79%	3.93%	3.44%

JOYY has higher revenue and earnings than GoodRx. JOYY is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.50
JOYY	$2.12B	1.35	$2.10B	$39.03	1.47

GoodRx has a beta of 1.54, meaning that its share price is 54% more volatile than the broader market. Comparatively, JOYY has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market.

In the previous week, GoodRx had 2 more articles in the media than JOYY. MarketBeat recorded 5 mentions for GoodRx and 3 mentions for JOYY. JOYY's average media sentiment score of 0.97 beat GoodRx's score of 0.59 indicating that JOYY is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
JOYY	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx currently has a consensus price target of $3.81, suggesting a potential upside of 53.11%. JOYY has a consensus price target of $74.67, suggesting a potential upside of 30.19%. Given GoodRx's higher probable upside, analysts plainly believe GoodRx is more favorable than JOYY.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
JOYY	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

JOYY beats GoodRx on 9 of the 16 factors compared between the two stocks.

How does GoodRx compare to Sezzle?

Sezzle (NASDAQ:SEZL) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Sezzle has higher earnings, but lower revenue than GoodRx. Sezzle is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sezzle	$480.91M	7.23	$133.13M	$4.21	24.57
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.50

Sezzle has a net margin of 30.83% compared to GoodRx's net margin of 2.61%. Sezzle's return on equity of 87.46% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sezzle	30.83%	87.46%	36.29%
GoodRx	2.61%	7.90%	3.23%

Sezzle has a beta of 6.91, suggesting that its stock price is 591% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.54, suggesting that its stock price is 54% more volatile than the broader market.

Sezzle currently has a consensus price target of $118.00, indicating a potential upside of 14.08%. GoodRx has a consensus price target of $3.81, indicating a potential upside of 53.11%. Given GoodRx's higher probable upside, analysts clearly believe GoodRx is more favorable than Sezzle.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sezzle	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

In the previous week, Sezzle had 19 more articles in the media than GoodRx. MarketBeat recorded 24 mentions for Sezzle and 5 mentions for GoodRx. GoodRx's average media sentiment score of 0.59 beat Sezzle's score of 0.51 indicating that GoodRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sezzle	7 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.0% of Sezzle shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 49.5% of Sezzle shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Sezzle beats GoodRx on 10 of the 16 factors compared between the two stocks.

How does GoodRx compare to Xometry?

GoodRx (NASDAQ:GDRX) and Xometry (NASDAQ:XMTR) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

GoodRx has a net margin of 2.61% compared to Xometry's net margin of -7.01%. GoodRx's return on equity of 7.90% beat Xometry's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
Xometry	-7.01%	-4.37%	-1.71%

GoodRx has a beta of 1.54, suggesting that its share price is 54% more volatile than the broader market. Comparatively, Xometry has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market.

In the previous week, Xometry had 20 more articles in the media than GoodRx. MarketBeat recorded 25 mentions for Xometry and 5 mentions for GoodRx. GoodRx's average media sentiment score of 0.59 beat Xometry's score of 0.59 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Xometry	9 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

63.8% of GoodRx shares are held by institutional investors. Comparatively, 97.3% of Xometry shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Comparatively, 9.1% of Xometry shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

GoodRx presently has a consensus price target of $3.81, indicating a potential upside of 53.11%. Xometry has a consensus price target of $76.00, indicating a potential downside of 15.54%. Given GoodRx's higher possible upside, analysts clearly believe GoodRx is more favorable than Xometry.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
Xometry	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

GoodRx has higher revenue and earnings than Xometry. Xometry is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.50
Xometry	$686.63M	6.79	-$61.74M	-$1.02	N/A

Summary

GoodRx beats Xometry on 10 of the 16 factors compared between the two stocks.

Get GoodRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GDRX vs. The Competition

Export

Metric	GoodRx	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$853.00M	$8.20B	$6.29B	$12.46B
Dividend Yield	N/A	2.92%	2.79%	5.30%
P/E Ratio	41.51	21.76	20.89	25.59
Price / Sales	1.07	16.92	522.17	62.83
Price / Cash	6.72	83.95	42.94	55.34
Price / Book	1.37	5.62	9.86	6.70
Net Income	$30.44M	$183.43M	$3.55B	$333.77M
7 Day Performance	-12.32%	0.13%	-0.32%	0.45%
1 Month Performance	11.66%	5.20%	1.33%	4.06%
1 Year Performance	-41.69%	4.75%	41.10%	36.24%

GoodRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDRX GoodRx	4.3857 of 5 stars	$2.49 -4.6%	$3.81 +53.1%	-39.3%	$853.00M	$796.85M	41.51	950	Analyst Forecast
PAGS PagSeguro Digital	4.9046 of 5 stars	$9.78 -1.0%	$12.00 +22.8%	-12.4%	$3.25B	$3.65B	7.64	8,595	News Coverage Earnings Report
YY JOYY	2.0161 of 5 stars	$58.85 -0.2%	$66.00 +12.1%	+35.9%	$3.17B	$2.24B	17.78	7,450
JOYY JOYY	4.8092 of 5 stars	$59.04 +0.3%	$74.67 +26.5%	N/A	$2.94B	$2.12B	1.51	5,815	News Coverage Analyst Upgrade
SEZL Sezzle	3.7897 of 5 stars	$85.96 +0.6%	$108.33 +26.0%	+13.1%	$2.89B	$450.28M	22.98	540	Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GDRX) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GoodRx (GDRX) Competitors

GDRX vs. PAGS, YY, JOYY, SEZL, and XMTR

How does GoodRx compare to PagSeguro Digital?

Summary

How does GoodRx compare to JOYY?

Summary

How does GoodRx compare to JOYY?

Summary

How does GoodRx compare to Sezzle?

Summary

How does GoodRx compare to Xometry?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDRX vs. The Competition

GoodRx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GoodRx (GDRX) Competitors

GDRX vs. PAGS, YY, JOYY, SEZL, and XMTR

How does GoodRx compare to PagSeguro Digital?

Which has more risk and volatility, PAGS or GDRX?

Do analysts rate PAGS or GDRX?

Does the media refer more to PAGS or GDRX?

Which has better valuation and earnings, PAGS or GDRX?

Do institutionals and insiders have more ownership in PAGS or GDRX?

Is PAGS or GDRX more profitable?

Summary

How does GoodRx compare to JOYY?

Which has more risk & volatility, GDRX or YY?

Which has better valuation and earnings, GDRX or YY?

Does the media favor GDRX or YY?

Do insiders & institutionals have more ownership in GDRX or YY?

Is GDRX or YY more profitable?

Do analysts recommend GDRX or YY?

Summary

How does GoodRx compare to JOYY?

Is GDRX or JOYY more profitable?

Which has preferable earnings and valuation, GDRX or JOYY?

Which has more risk & volatility, GDRX or JOYY?

Does the media prefer GDRX or JOYY?

Do analysts recommend GDRX or JOYY?

Do insiders & institutionals hold more shares of GDRX or JOYY?

Summary

How does GoodRx compare to Sezzle?

Which has better earnings & valuation, SEZL or GDRX?

Is SEZL or GDRX more profitable?

Which has more volatility and risk, SEZL or GDRX?

Do analysts prefer SEZL or GDRX?

Does the media prefer SEZL or GDRX?

Do institutionals and insiders believe in SEZL or GDRX?

Summary

How does GoodRx compare to Xometry?

Is GDRX or XMTR more profitable?

Which has more risk and volatility, GDRX or XMTR?

Does the media refer more to GDRX or XMTR?

Do institutionals & insiders believe in GDRX or XMTR?

Do analysts recommend GDRX or XMTR?

Which has preferable valuation and earnings, GDRX or XMTR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDRX vs. The Competition

GoodRx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools